ASH Clinical News ACN_5.7_Digital | Page 14

Calendar
European Hematology Association
Annual Congress
June 13 – 16, 2019
Amsterdam, The Netherlands
The 24th Annual Congress covers every subspecialty in
hematology, with experts from around the world sharing
original data and discussing the latest evidence-based
approaches to treating hematologic disorders.
International Conference on
Malignant Lymphoma
June 18 – 22, 2019
Lugano, Switzerland
At the 15th International Conference on Malignant
Lymphoma, the scientific community involved in the
study and treatment of lymphoid neoplasms present
the latest basic and translational science in the field.
Amsterdam, The Netherlands
FACTOR REPLACEMENT MIRRORS
THE PROTECTION WITHIN
International Society on Thrombosis and
Haemostasis’ Congress and Annual Scientific
and Standardization Committee Meeting
July 6 – 10, 2019
Melbourne, Australia
The International Society on Thrombosis and Haemo-
stasis’ 2019 Congress, a global meeting in thrombosis,
hemostasis, and vascular biology, will be attended by
thousands of the world’s experts.
International Society for Experimental
Hematology Annual Scientific Meeting
August 22 – 25, 2019
Brisbane, Australia
The 48th Annual Scientific Meeting of the Interna-
tional Society for Experimental Hematology blends
educational sessions on basic, translational, and
clinical hematology with unique networking oppor-
tunities for senior scientists and new investigators.
Chicago, IL
ASH Meeting on Hematologic
Malignancies
September 6 – 7, 2019
Chicago, IL
Top experts in hematologic malignancies discuss
the latest developments in clinical care and provide
answers to challenging patient care questions
in a small-group setting. The program content
is structured as “How I Treat” presentations,
which showcase each speaker’s evidence-based
treatment approaches.
2019 ASTRO Annual Meeting
September 15 – 18, 2019
Chicago, IL
The annual meeting of the American Society for
Radiation Oncology provides a forum for more
than 11,000 attendees to discuss the translation of
scientific discoveries into clinical applications and
opportunities for cure.
For your patients with Hemophilia A,
Factor treatment has a long history of results. 1
It temporarily replaces what’s missing and is regulated
by the natural hemostatic process to form a proper clot. 2-5
Brought to you by Takeda, dedicated to pursuing
advancements in hemophilia for more than 70 years.
Explore an established treatment option in hemophilia
References: 1. Franchini M, Mannucci PM. The history of hemophilia. Semin Thromb Hemost. 2014;40:571-576. 2. Peyvandi F, Garagiola I, Young G. The past
and future of haemophilia: diagnosis, treatments, and its complications. Lancet. 2016;388:187-197. 3. Lenting PJ, van Mourik JA, Mertens K. The life cycle of
coagulation factor VIII in view of its structure and function. Blood. 1998;92(11):3983-3996. 4. Antovic A, Mikovic D, Elezovic I, Zabczyk M, Hutenby K, Antovic JP.
Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand. Thromb Haemost. 2013;111(4):656-661. 5. Hvas AM,
Sørensen HT, Norengaard L, Christiansen K, Ingerslev J, Sørensen B. Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated
fibrinolysis in severe hemophilia A. J Thromb Haemost. 2007;5:2408-2414.
Copyright © 2019 Takeda Pharmaceutical Company Limited. 300 Shire Way, Lexington, MA 02421. 1-800-828-2088.
All rights reserved. TAKEDA and the TAKEDA logo are trademarks
or registered trademarks of Takeda Pharmaceutical Company Limited. S46147 03/19
XVIII International Workshop on
Chronic Lymphocytic Leukaemia
September 20 – 23, 2019
Edinburgh, Scotland
The 2019 meeting of the International Workshop
on Chronic Lymphocytic Leukaemia will bring
together expert hematologists, clinicians, and
researchers to discuss recent developments in the
understanding of disease biology and treatments.
MARK YOUR CALENDAR
2019 American Society of
Hematology Annual Meeting
December 7 – 10, 2019
Orlando, FL
The 61st ASH Annual Meeting and Exposition
will provide an invaluable educational
experience and the opportunity to review
thousands of scientific abstracts highlighting
updates in the hottest topics in hematology.
June 2019